Paper Details

  1. Home
  2. Paper Details

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.

Author: CastaldoRichard S, CelliBartolome R, GomezFernando, HanrahanJohn P, LaValleeNicole, SouhradaJoseph

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The study discussed the use of macrolide antibiotics, particularly dirithromycin and azithromycin, in treating acute exacerbations of chronic bronchitis (AECB).
Paper Details　
Original Abstract of the Article :
Short-term use of antibiotics has become a common component of the management of acute exacerbations of chronic bronchitis (AECB), particularly in complex cases with productive cough or purulent phlegm. The macrolide antibiotics, particularly second-generation agents such as dirithromycin and azithr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0149-2918(03)80095-4

データ提供：米国国立医学図書館（NLM）

Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD): Finding Relief in the Desert

This research explores the effectiveness of two macrolide antibiotics, dirithromycin and azithromycin, in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The authors compared the efficacy of 5-day courses of these two antibiotics.

Dirithromycin and Azithromycin: A Potential Oasis

The study found that both dirithromycin and azithromycin were effective in treating AECOPD, but no specific findings regarding the relative efficacy of each drug were presented in the abstract. It's like finding two oases in the desert, each offering a potential source of relief.

AECOPD: A Desert of Challenges

AECOPD is a common and debilitating condition that can significantly impact a person's quality of life. This research highlights the importance of effective antibiotic treatment for managing exacerbations of the disease.

Dr.Camel's Conclusion

This research provides insights into the effectiveness of macrolide antibiotics for AECOPD. It's like finding a guide through the desert of respiratory illness, offering a potential treatment option for a challenging condition. Further research is needed to clarify the relative efficacy of dirithromycin and azithromycin for AECOPD, as well as to determine the optimal duration of treatment.
Date :
  1. Date Completed 2003-07-10
  2. Date Revised 2019-09-22
Further Info :

Pubmed ID

12749513

DOI: Digital Object Identifier

10.1016/s0149-2918(03)80095-4

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.